https://seekingalpha.com/article/4237817-clearbridge-cap-value-strategy-portfolio-manager-commentary-q4-2018?source=feed_all_articles
Feb 04, 2019 - ClearBridge is a leading global asset manager committed to active management. Research-based stock selection guides our investment approach, with our strategies reflecting the highest-conviction ideas
0
sa:532058585766147635
0
http://www.zacks.com/stock/news/351843/stock-market-news-for-feb-4-2019?cid=CS-ZC--351843
Feb 04, 2019 - Markets closed mostly in the green on Friday after the release of stellar economic data boosted investor sentiment.
zc:-7050168936794202683
0
https://seekingalpha.com/article/4237704-week-review-new-shanghai-hi-tech-exchange-ipo-pre-revenue-companies?source=feed_sector_healthcare
Feb 03, 2019 - The Shanghai Stock Exchange's new Technology Innovation Board will allow still-unprofitable hi-tech companies - including biopharmas - to IPO on the exchange, though each IPOing company must have a va
0
sa:-2228273373359314399
0
http://www.gurufocus.com/news/809222/dow-sp-500-close-higher-friday-on-strong-january-jobs-report
Feb 01, 2019 - Dow, S&P 500 Close Higher Friday on Strong January Jobs Report, Stocks: V,XOM,MRK,CVX,AMZN,WMT,CAT, release date:Feb 01, 2019
0
gf:-4781927033076158037
0
http://www.gurufocus.com/news/808934/wall-street-green-on-positive-jobs-report
Feb 01, 2019 - Wall Street Green on Positive Jobs Report, Stocks: MRK,VLO,MU,SYMC,AON,XOM,HES,MU,ALGN,TGT,M, release date:Feb 01, 2019
0
gf:-5511427988263980347
0
https://seekingalpha.com/article/4237499-merck-and-co-inc-mrk-q4-2018-results-earnings-call-transcript?source=feed_sector_healthcare
Feb 01, 2019 - Merck & Co Inc. (NYSE:MRK) Q4 2018 Earnings Conference Call February 01, 2019 08:00 AM ET Company Participants Teri Loxam - IR Ken Frazier - Chairman and CEO Rob Davis - CFO Roger Perlmutter - Pre
0
sa:6928205980388088099
0
https://seekingalpha.com/article/4237483-ipo-update-anchiano-therapeutics-files-35-million-ipo?source=feed_tag_israel
Feb 01, 2019 - Anchiano Therapeutics intends to sell $35 million of its ADSs in an IPO.The firm is developing a number of cancer treatment from its lead candidate Inodiftagene.Early trial results have been promising
0
sa:5756514910577345729
0
https://seekingalpha.com/article/4237450-merck-and-co-inc-2018-q4-results-earnings-call-slides?source=feed_sector_healthcare
Feb 01, 2019 - The following slide deck was published by Merck & Co Inc. in conjunction with their 2018 Q4 earnings call.
0
sa:3098384952841631835
0
http://www.zacks.com/stock/news/351474/merck-mrk-tops-on-q4-earnings-sales-stock-up?cid=CS-ZC-FT-351474
Feb 01, 2019 - Merck (MRK) beats estimates for earnings as well as sales in fourth-quarter 2018. Stock is up in pre-market trading.
zc:7190503543540481496
0
https://seekingalpha.com/article/4237035-tao-dogs-dow-load-rinse-repeat-next-year?source=feed_all_articles
Jan 31, 2019 - 30 Dow stocks represent nine of 11 sectors. Dow tracks utilities as a separate index and omits real estate. Broker top 10 target-estimated net gains ranged from 15.03% to 24.49%.Top Dow dog by yield w
0
sa:9138551477563039600
0